Skip to main content
. 2020 Aug 7;3(8):e2012598. doi: 10.1001/jamanetworkopen.2020.12598

Table 2. Association of Mindfulness-Based Interventions With Short-Term Anxiety by Patient, Intervention, and Methodological Factors in 28 Included Studies.

Subgroup Trials, No. Patients, No. SMD (95% CI) I2, % P value for interaction
Type of cancer
Breast 10 1224 −0.40 (−0.62 to −0.17) 68 .33
>1 Cancer and other cancer types 14 1115 −0.57 (−0.86 to −0.29) 76
Cancer stage
Nonmetastatic 10 1209 −0.52 (−0.73 to −0.31) 69 .31
Metastatic 0 0 NA
Metastatic and nonmetastatic 7 686 −0.36 (−0.55 to −0.16) 37
Timing of intervention
During cancer treatment 3 183 −1.16 (−1.94 to −0.38) 78 .19
After cancer treatment 9 966 −0.43 (−0.70 to −0.17) 71
Both during and after cancer treatment 9 989 −0.39 (−0.68 to −0.11) 76
Intervention type
Mindfulness-based stress reduction 11 1376 −0.32 (−0.49 to −0.14) 57 .52
Mindfulness-based cognitive therapy 7 604 −0.32 (−0.53 to −0.12) 31
Mindfulness-based art therapy 2 117 −1.41 (−3.36 to 0.54) 91
Mindfulness-based cancer recovery 1 33 −0.78 (−1.64 to 0.08) NAa
Delivery setting
Group 21 2067 −0.39 (−0.54 to −0.24) 60 .07
Nongroup 3 272 −1.19 (−2.05 to −0.34) 90
Length of intervention, wks
<8 7 715 −0.78 (−1.27 to −0.29) 88 .14
≥8 17 1624 −0.39 (−0.57 to −0.21) 71
Adequate sequence generation
Yes 18 2028 −0.43 (−0.61 to −0.26) 71 .23
Unclear 6 311 −0.83 (−1.46 to −0.21) 82
Adequate allocation concealment
Yes 10 1361 −0.36 (−0.54 to −0.17) 63 .32
Unclear 14 978 −0.68 (−1.02 to −0.34) 76

Abbreviations: NA, not applicable; SMD, standardized mean difference.

a

I2 is not calculated here because only 1 study reported this outcome.